These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 83324)
1. Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids. Rifkin DB J Cell Physiol; 1978 Dec; 97(3 Pt 2 Suppl 1):421-8. PubMed ID: 83324 [TBL] [Abstract][Full Text] [Related]
2. Studies on the control of plasminogen activator production by cultured human embryonic lung cells: requirements for inhibition by corticosteroids. Rifkin DB; Crowe RM J Cell Physiol; 1980 Dec; 105(3):417-22. PubMed ID: 7193216 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Busso N; Belin D; Failly-Crépin C; Vassalli JD Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA. Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417 [TBL] [Abstract][Full Text] [Related]
5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Blei F; Wilson EL; Mignatti P; Rifkin DB J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid sensitivity of OVCA 433 human ovarian carcinoma cells: inhibition of plasminogen activators, cell growth, and morphological alterations. Amin W; Karlan BY; Littlefield BA Cancer Res; 1987 Nov; 47(22):6040-5. PubMed ID: 3117361 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors. Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056 [TBL] [Abstract][Full Text] [Related]
9. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. Michel JB; Quertermous T J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387 [TBL] [Abstract][Full Text] [Related]
10. Heparin potentiates endothelial cell growth factor stimulation of plasminogen activator synthesis by diploid human lung fibroblasts. Rappaport RS; Ronchetti-Blume M; Vogel RL; Hung PP Thromb Haemost; 1988 Jun; 59(3):514-22. PubMed ID: 2460964 [TBL] [Abstract][Full Text] [Related]
11. Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells. Kuo BS; Korner G; Dryjski M; Bjornsson TD J Cell Physiol; 1988 Oct; 137(1):192-8. PubMed ID: 3139680 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680 [TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes. Bator JM; Cohen RL; Chambers DA Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808 [TBL] [Abstract][Full Text] [Related]
14. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate. Wilson MJ; Ludowese C; Sinha AA; Estensen RD Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400 [TBL] [Abstract][Full Text] [Related]
15. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells. Phan Thu A; Popovic M Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents. McLean JS; Frame MC; Freshney RI; Vaughan PF; Mackie AE; Singer I Anticancer Res; 1986; 6(5):1101-6. PubMed ID: 2879508 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids inhibit plasminogen activator production by endothelial cells. Laug WE Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927 [TBL] [Abstract][Full Text] [Related]
18. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964 [TBL] [Abstract][Full Text] [Related]
19. Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator. Seifert SC; Gelehrter TD J Cell Physiol; 1979 Jun; 99(3):333-41. PubMed ID: 457795 [TBL] [Abstract][Full Text] [Related]
20. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix. Niedbala MJ; Sartorelli AC Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]